Pro forma scale arrives with heavy dilution, bill credits, and goodwill

This is mostly confirmation, not a new deal surprise. The merger terms remain the previously announced 0.8138 NEE shares plus $360 million of cash for Dominion holders, and closing still depends on shareholder, antitrust, and multiple state and federal regulatory approvals (Merger overview). The earlier transaction case targeted 9%+ adjusted EPS growth, but this filing does not provide a directly comparable adjusted-EPS bridge or published consensus; its GAAP pro forma figures therefore cannot substantiate a beat or miss.

The combined company is materially larger, but the share count rises sharply. The transaction would issue approximately 737.6 million NEE shares, lifting pro forma basic shares to 2.82 billion from NEE's standalone 2.08 billion (Earnings per share calculation). That is roughly 36% share-count dilution, while Dominion contributes $16.5 billion of 2025 revenue and $3.0 billion of net income attributable to NEE presentation (Pro Forma Combined Statement of Income). The filing's $3.19 pro forma 2025 GAAP EPS is not evidence of accretion because the filing does not provide a standalone NEE adjusted-EPS comparison on the same basis.

The clearest near-term drag is the $2.25 billion customer-credit commitment. The filing reduces pro forma revenue by $563 million for the first six months and by $996 million for 2025 after including the credit recognition and related purchase-accounting effects (Note 4J; Pro Forma Combined Statement of Income). Those credits are spread over 24 months after closing, so the reported revenue and earnings profile will be pressured during the early integration period rather than benefiting immediately from the enlarged asset base.

The balance sheet highlights transaction risk more than operating improvement. Estimated consideration is $65.2 billion for only $25.2 billion of estimated net assets, producing $40.1 billion of preliminary goodwill (Preliminary Purchase Price Allocation). Pro forma debt is approximately $153.8 billion, including current maturities and commercial paper, while cash falls to $2.6 billion after estimated closing costs (Pro Forma Combined Balance Sheet). The filing also estimates $500 million of total merger costs, including $455 million still to be recorded, so the financial benefits remain dependent on successful regulatory clearance, integration, and eventual realization of the strategic rationale rather than being demonstrated in this filing.